NIH Reporter #5P30CA069533-28

Cancer Biology Research Grant for OHSU from NIH/NCI

This opportunity is a research grant from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), supporting the Cancer Biology Research Program at Oregon Health & Science University (OHSU). - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - No specific OEMs or commercial vendors are named in the solicitation - Products/Services Requested: - Research services in cancer biology - Focus areas include: - Tumorigenesis - Genetic instability - Signal transduction - Tumor microenvironment - No specific products, part numbers, or purchase quantities are listed - Unique/Notable Requirements: - Emphasis on integrative research to discover new therapeutic mechanisms and targets for cancer therapy - Funding amount is $99,709 for the year - Opportunity is for research services, not product procurement

Description

This NIH grant opportunity is for the Cancer Biology Research Program at Oregon Health & Science University, funded by the National Cancer Institute (NCI). The program focuses on discovering novel therapeutic mechanisms and targets for cancer therapy through integrative investigation of genetic, molecular, and cellular processes underlying cancer initiation and progression. Research spans tumorigenesis, genetic instability, signal transduction, and tumor microenvironment, supporting advances in precision oncology and early detection. The project duration is from August 1, 1997 to June 30, 2027, with a funding amount of $99,709 for the year 2026.

View original listing